Published in Clin Transplant on February 19, 2009
Management of anticoagulation for portal vein thrombosis in individuals with cirrhosis: a systematic review. Int J Hepatol (2012) 1.08
Portal vein thrombosis in cirrhosis: Controversies and latest developments. World J Gastroenterol (2015) 0.94
Portal vein thrombosis. J Clin Exp Hepatol (2015) 0.92
Clinical Management of Acute Portal/Mesenteric Vein Thrombosis. Viszeralmedizin (2014) 0.91
Etiology and Complications of Portal Vein Thrombosis. Viszeralmedizin (2014) 0.88
Therapy Algorithm for Portal Vein Thrombosis in Liver Cirrhosis: The Internist's Point of View. Viszeralmedizin (2014) 0.87
What we should know about portal vein thrombosis in cirrhotic patients: a changing perspective. World J Gastroenterol (2012) 0.86
Portal vein thrombosis in cirrhosis. J Clin Exp Hepatol (2013) 0.77
Liver transplantation in a patient with complete portal vein thrombosis, is there a surgical way out? A case report. Ann Med Surg (Lond) (2016) 0.75
[Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres]. Z Gastroenterol (2011) 1.07
Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis. Mucosal Immunol (2008) 1.01
Liver retransplantation--indications, frequency, results. Transplant Proc (1992) 0.98
Impact of liver cirrhosis on liver enhancement at Gd-EOB-DTPA enhanced MRI at 3 Tesla. Eur J Radiol (2013) 0.95
Survival benefit in patients after palliative resection vs non-resection colon cancer surgery. World J Gastroenterol (2006) 0.94
Severe renal vein stenosis of a kidney transplant with beneficial clinical course after successful percutaneous stenting. Am J Transplant (2008) 0.94
Hepatic progenitor cells from adult human livers for cell transplantation. Gut (2008) 0.93
Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma. Histopathology (2005) 0.93
Percutaneous transluminal angioplasty as first-line treatment of transplant renal artery stenosis. Clin Nephrol (2009) 0.91
Prognostic value of the monoethylglycinexylidide (MEGX)-test prior to liver resection. Hepatogastroenterology (2008) 0.85
SDF-1 expression is elevated in chronic human renal allograft rejection. Clin Transplant (2006) 0.84
Who is willing to take the risk? Assessing the readiness for living liver donation in the general German population. J Med Ethics (2006) 0.83
[Cholestasis and vomiting: unusual differential diagnosis in a case of Peutz-Jeghers syndrome]. Dtsch Med Wochenschr (2003) 0.82
[Surgical treatment of liver metastases]. Chirurg (2010) 0.82
A cell penetrating heme oxygenase protein protects heart graft against ischemia/reperfusion injury. Gene Ther (2008) 0.81
Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results. Clin Hemorheol Microcirc (2011) 0.80
Mini-incision for strictly retroperitoneal nephrectomy in living kidney donation vs flank incision. Nephrol Dial Transplant (2006) 0.80
[Surgical therapy of benign liver tumors]. Chirurg (2008) 0.80
Cardiovascular risk estimates and risk factors in renal transplant recipients. Transplant Proc (2005) 0.80
[Biliodigestive anastomosis: indications, complications and interdisciplinary management]. Chirurg (2012) 0.80
Pretransplant calcium levels have no predictive value for delayed graft function, long-term graft function, cardiovascular events, or graft and patient survival in renal transplantation. Transplant Proc (2006) 0.79
Prolongation of heart allograft survival after long-term expression of soluble MHC class I antigens and vIL-10 in the liver by AAV-plasmid-mediated gene transfer. Langenbecks Arch Surg (2008) 0.78
Steroid withdrawal or steroid avoidance in renal transplant recipients: focus on tacrolimus-based immunosuppressive regimens. Transplant Proc (2005) 0.78
Postoperative assessment of free skin flap viability by transcutaneous pO2 measurement using dynamic phosphorescence imaging. Clin Hemorheol Microcirc (2009) 0.78
Characterization of microvascularization of liver tumor lesions with high resolution linear ultrasound and contrast enhanced ultrasound (CEUS) during surgery: First results. Clin Hemorheol Microcirc (2010) 0.78
Contrast harmonic imaging ultrasound and perfusion imaging for surveillance after endovascular abdominal aneurysm repair regarding detection and characterization of suspected endoleaks. Clin Hemorheol Microcirc (2009) 0.77
Five-year follow-up after late conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction. Transplant Proc (2007) 0.77
Long-term outcome after multivisceral and tumor/vascular resection in patients with soft tissue sarcoma. Langenbecks Arch Surg (2008) 0.76
Calcineurin inhibitor sparing with mycophenolate mofetil in liver transplantion: a systematic review of randomized controlled trials. Am J Transplant (2012) 0.76
Soluble donor MHC class I gene transfer to thymus promotes allograft survival in a high-responder heart transplant model. Transpl Int (2000) 0.76
Eosinophilic cholangitis and wirsungitis as cause of simultaneous bile duct obstruction and pancreatitis. Z Gastroenterol (2012) 0.75
Effective use of donor MHC class I gene therapy in organ transplantation: prevention of antibody-mediated hyperacute heart allograft rejection in highly sensitized rat recipients. Hum Gene Ther (2000) 0.75
Cholesterol crystal embolism: Diagnostic and treatment. Kidney Int (2006) 0.75
Expression of high levels of soluble allogeneic major histocompatability complex class I antigen by adenoviral gene transfer strongly inhibits allospecific cytotoxic T lymphocytes in vivo. Transplant Proc (2002) 0.75
Paclitaxel promotes liver graft survival in rats and inhibits hepatocellular carcinoma growth in vitro and is a potentially useful drug for transplant patients with liver cancer. Transplant Proc (2002) 0.75
Soluble donor MHC class I antigen inhibits immunologic priming in vitro and in vivo. Transpl Int (1998) 0.75
[Primary hyperparathyroidism: clinical symptoms, diagnostic significance and localisation--a retrospective analysis]. Zentralbl Chir (2007) 0.75
Expression of soluble allo-MHC class I antigen in vivo suppresses IL-2 production by allo-reactive helper T cells. Transplant Proc (1999) 0.75
An adenoviral gene transfer system to express high levels of soluble allogeneic MHC class I molecules in vitro and in vivo. Transplant Proc (2002) 0.75
[Pararectal mini-incision for strictly retroperitoneal nephrectomy in living kidney donation]. Urologe A (2006) 0.75
Innovations in contrast enhanced high resolution ultrasound improve sonographic imaging of the intestine. Clin Hemorheol Microcirc (2010) 0.75
Early experience shows rapid shrinking of abdominal aortic aneurysms after endovascular treatment with Anaconda device. Vasa (2007) 0.75
The impact of "high-producer" interleukin-6 haplotypes on cardiovascular morbidity and mortality in a kidney transplant population. Transplant Proc (2009) 0.75
[Quality of life of German surgeons: results of a survey of 3,652 attendees of the annual meetings of the German Surgical Societies ]. Dtsch Med Wochenschr (2011) 0.75
[Split-liver transplantation]. Chirurg (2008) 0.75
[Prevention of early rejection by soluble MHC class I antigen after allogenic liver transplantation]. Langenbecks Arch Chir Suppl Kongressbd (1998) 0.75
[Prevention of organ failure in an organ donor. Early identification and maximum protective therapy after multiple trauma]. Dtsch Med Wochenschr (2006) 0.75
[Localisation of hepatic lesions to liver segments according to sonography (US), computed tomography (CT) and surgery (OP): a comparative study]. Z Gastroenterol (2010) 0.75
Soluble donor MHC class I gene therapy prevents accelerated heart allograft rejection in actively sensitized rat recipients. Transplant Proc (2001) 0.75
[Case report--surgical therapy of a retroperitoneal liposarcoma weighing 45 kg]. Zentralbl Chir (2009) 0.75
Immunologic suppression mediated by genetically modified hepatocytes expressing secreted allo-MHC class I molecules. Hum Immunol (1998) 0.75
[Liver transplantation in elderly patients: indications, risks and results]. Langenbecks Arch Chir Suppl Kongressbd (1996) 0.75
Experiences with a simplified liver harvesting technique--single aorta in situ flush followed by portal back table flush. Transplant Proc (1993) 0.75
Conditioning of liver grafts with prostaglandins improves bile acid transport. Transplant Proc (2005) 0.75